SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Giulio Sinigiani et al.|Journal of the American College of Cardiology|2024Cited by 137
Value of the <scp>HFA‐PEFF</scp> and <scp> H <sub>2</sub> FPEF </scp> scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosisDaniela Tomasoni, Marco Metra, Alberto Aimo et al.|European Journal of Heart Failure|2022Cited by 43